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Edited by Francesc PosasAbstract Jumonij (JMJ)/Jarid2 plays important roles in
embryonic development and functions as a transcriptional repres-
sor. Using yeast two-hybrid screening, we have identiﬁed a cofac-
tor of JMJ, the zinc ﬁnger protein 496 (Zfp496) that contains a
SCAN, KRAB and zinc ﬁnger domain. Our molecular analyses
indicate that Zfp496 functions as a transcriptional activator.
Further, Zfp496 inhibits the transcriptional repression of JMJ
and JMJ represses the transcriptional activation of Zfp496. This
study demonstrates that JMJ physically and functionally inter-
acts with Zfp496, which will provide important insights into
endogenous target gene regulation by both factors.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Development1. Introduction
Signiﬁcant advances have recently been made in understand-
ing the role of transcription factors during embryonic develop-
ment including heart development. Transcription factors that
play critical developmental roles in the heart belong to many
diﬀerent transcription factor families. These include, but are
not limited to, the homeodomain protein Nkx2.5 [1], the zinc
ﬁnger protein GATA4 [2,3], the MADS box factor MEF2C
[4,5], and the T-box transcription factor Tbx5 [6]. Loss of these
transcription factors in mice results in early embryonic lethal-
ity due to cardiac defects. Increasing evidence indicates that
complex interactions among multiple trans-acting factors pos-
itively or negatively regulate the target gene expression.
Nkx2.5 activates expression of atrial natriuretic factor
(ANF) by binding to the enhancer region [7,8], and interacts
cooperatively with other transcription factors including
GATA4 and PITX2C [9]. GATA4 interacts with FOG-2
(friend of GATA), which results in repressing GATA4 activi-
ties [10]. Tbx5 synergistically activates the ANF promoter with
GATA4 and Nkx2.5 [11], while Tbx20 represses the ANF acti-
vation mediated by Tbx5 [12].
By searching for developmentally important genes, the jum-
onji gene (jmj) was identiﬁed as a critical nuclear factor for
mouse embryonic development including cardiovascular devel-*Corresponding author. Fax: +1 608 262 7306.
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doi:10.1016/j.febslet.2007.05.006opment [13,14] (for review see [15]). Jmj has recently been
renamed Jarid2 according to NCBI nomenclature but will be
referred to in this manuscript as jmj. JMJ belongs to the AT-
rich interaction domain (ARID) transcription factor family
[16–18], and is a member of the Jumonji transcription factor
family [19,20]. Recently, members of the Jumonji transcription
factor family including JHDM1 [21], JHDM2A [22], and
JMJD2A [23] have been shown to exhibit histone demethylase
activity. However, the function of JMJ as a histone modiﬁer
remains to be elucidated. We have previously reported that
knockout of jmj results in heart malformations, which mimic
human congenital heart diseases (for review see [15]). Our
structural/functional analyses of JMJ indicate that JMJ func-
tions as a transcriptional repressor and inhibits ANF activa-
tion by Nkx2.5 and GATA4 [24,25]. JMJ is involved in
regulating cardiomyocyte proliferation in a temporal- and spa-
tial-dependent manner [26,27]. At the molecular level, JMJ
represses cardiomyocyte proliferation through interaction with
the retinoblastoma protein [28].
Although the functional roles of JMJ are emerging in asso-
ciation with embryonic development, the molecular mecha-
nisms by which JMJ functions remain largely unknown.
Therefore, we performed a yeast two-hybrid screen to identify
novel cofactors of JMJ, which would lead us to determine crit-
ical factors for target gene regulation. Using JMJ as bait, a
zinc ﬁnger protein 496 (Zfp496) was identiﬁed whose function
remains unknown. Zfp496 consists of three distinct domains.
The SCAN domain, which is also called LeR because it is a
leucine-rich region, is a protein interaction domain that medi-
ates both self-association and association with other SCAN-
box proteins. A KRAB domain functions as a transcriptional
repressor when tethered to the template DNA by a DNA-
binding domain (for review see [29]). Zinc ﬁnger regions of
proteins are thought to interact directly in both protein-
DNA interactions and protein–protein interactions. Zfp496
contains ﬁve zinc ﬁnger regions, of which four are conven-
tional C2H2 ﬁngers, while one is a novel C2HR motif [30].
KRAB-zinc ﬁnger proteins probably constitute the single larg-
est class of transcription factors within the human genome
[31]. Nielsen et al. [30] recently reported Zfp496 as Nizp1
(NSD1-interacting zinc ﬁnger protein) while we were charac-
terizing the function of this protein. NSD1 (Nuclear recep-
tor-binding SET-domain containing protein), the histone
lysine methyltransferase, was initially identiﬁed to interact
with retinoic acid receptor and exhibited characteristics of
both corepressors and coactivators [32].
In this study, we show that JMJ physically interacts with
Zfp496 in vivo and in vitro. Interestingly, Zfp496 functions asblished by Elsevier B.V. All rights reserved.
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directly binding to the DNA binding motif. Further we show
that JMJ and Zfp496 are able to attenuate each other’s tran-
scriptional activity. The complex interactions among transcrip-
tion factors are the key regulatory components of the
temporal- and spatial-expression of target genes. These ﬁnd-
ings will provide the important basis to further study the
endogenous gene regulation by JMJ and Zfp496.2. Materials and methods
2.1. Yeast two-hybrid screening
To identify cofactors that interact with JMJ, a yeast two-hybrid
screen was performed using a bait containing the full length JMJ.
A mouse embryonic expression library was screened according to
the manufacturer’s recommendation (OriGene Technologies, Inc).
Putative positive library plasmids were recovered from yeast and sub-
jected to conﬁrmation mating experiments by streaking the two yeast
strains containing a bait or a potential positive cDNA. For positives
that passed conﬁrmation tests, the cDNAs were identiﬁed by
sequencing and Blasting against the NCBI GenBank sequence. A to-
tal of 25 independent positive clones were recovered and sequenced.
Among several potential cofactors selected according to our criteria
such as nuclear localization and putative transcription activity,
Zfp496 was further characterized as a potential JMJ cofactor in this
study.2.2. Plasmid constructs
The recovered cDNA from yeast contained nucleic acids 1590–2375
of Zfp496 that encodes amino acids (aa) 450-585 when compared to
the published sequence (GenBank Accession No. gi25955548). The full
length coding sequence of Zfp496 was obtained by RT-PCR ampliﬁca-
tion with gene speciﬁc primers, and veriﬁed by sequencing. Zfp496
mutant constructs in the pcDNA3.1/myc-His () B (Invitrogen),
GAL4-DNA-binding domain (DBD)/pcDNA3.1/Xpress vector, and
the glutathione S-transferase (GST)-Zfp496 plasmid (pGEX-2T,
Amersham) were generated as previously described [24]. All JMJ con-
structs used were previously described [24]. The reporter gene pG5Ti
consisted of 5X GAL4 binding sites upstream of the adenovirus major
late promoter TATA box linked to luciferase (obtained from Dr. P.
Farnham) [33]. SAAB reporter constructs were generated by tandem
ligation of the SAAB oligonucleotides followed by subcloning into
pcRII-TOPO vector (Invitrogen). The oliognucleotide inserts were
excised using XhoI and SacI and ligated into a pGL2 vector (Promega)
containing an E1B promoter (obtained from Dr. Eric Olson). The
ligated sequences for the reporter constructs are: pGL2-E1B-4X SAAB
#3 5 0-CTATTACTTGTAT-3 0; pGL2-E1B-5X SAAB #4 5 0-ATTA-
ATTATTGATCA-3 0; and pGL2-E1B-5X SAAB #18 5 0-AACTGGC-
CATCCAGC-3 0.2.3. Protein–protein interaction
To examine the in vivo association of Zfp496 with JMJ, coimmuno-
precipitation was performed as previously described [8,28,30] with
minor modiﬁcations. These modiﬁcations include preclearing the nu-
clear extract by incubation with mouse immunoglobulin G (IgG)
and protein G-agarose (Sigma) for 1 h before 3 lg of anti-myc (Santa
Cruz Biotechnology) or anti-FLAG (Sigma) antibody was added. The
immunoprecipitates were analyzed by Western blotting with anti-myc
or anti-FLAG antibody. For a semi in vivo approach to the coimmu-
noprecipitation, heart extracts from 7 day old mice were prepared
using a buﬀer containing 0.2% SDS, 11% glycerol, 11 mM Tris (pH
8.0), 1.1 mM EDTA (pH 8.0), 1 mM DTT and protease inhibitors.
Hearts were homogenized and then subjected to sonication before a
ﬁnal centrifugation at 15000 · g at for 30 min. 2 mg of total protein
extract was diluted 1:10 in NETN buﬀer (20 mM Tris–HCl, pH 8.0,
100 mM NaCl, 1 mM EDTA, and 0.5% NP-40) containing 1 mM
DTT and protease inhibitors. The extract was pre-cleared with GST
beads and then incubated at 4 overnight with 5 lg of GST-Zfp496
beads or GST-beads. The bound proteins were subjected to Western
blotting using a JMJ-P100 antibody [24].To map the protein–protein interaction domains between Zfp496
and JMJ, GST pull-down assays were performed [8] using the TNT
T7 Coupled Reticulocyte Lysate System (Promega). 35S-methionine
labeled proteins were incubated in NETN buﬀer with GST-glutathione
beads, GST-Zfp496 beads, GST-J-Nt (N-terminal, aa 1–528) beads or
GST-J-Ct (C-terminal, aa 529–1234) beads. 35S-labeled FL Zfp496
consists of aa 1–585, 35S-Zfp496 SCAN only consists of aa 1–198,
35S-Zfp496 KRAB only consists of aa 155–333, and 35S-Zfp496 zinc
only consists of aa 333–585. For the reciprocal experiment, 35S-FL
JMJ (aa 1–1234), 35S-JMJ (aa 1–220), 35S-JMJ (aa 1–130), and
35S-JMJ (aa 131–222) were used.
2.4. Reporter gene assay, gel mobility shift assay (GMSA), and
immunostaining
10T1/2 cells were transfected using calcium phosphate precipitation
method [8], or Lipofectamine 2000 (Invitrogen). Data are given as
means ± S.E. of the mean. Statistical analyses were performed using
the Student’s paired t-test. Results were accepted as signiﬁcant when
P was <0.05, which is indicated by [*]. To examine whether Zfp496
binds to DNA in vitro, GMSAs were performed as described previ-
ously [34]. Indirect immunostaining experiments were described else-
where [13].
2.5. Site selection and ampliﬁcation of binding (SAAB)
To identify the DNA-binding consensus sequences of Zfp496, the
SAAB method was carried out as described previously [24,35,36] with
minor modiﬁcations. A random sequence library was prepared by syn-
thesizing oligonucleotide pools comprising a random 15-bp sequence
ﬂanked by 18 base linker sequences 5 0-GCGAAGCTTTGACT-
GAGG(N15)TTGATGCCGAGGATCCCG-3 0 (Integrated DNA
Technologies). BamHI and HindIII sites are underlined. The PCR
primers annealing to the 18 bases of each top and bottom strand were
synthesized (5 0 sense: 5 0-GCGAAGCTTTGACTGAGG; 3 0 anti-sense:
5 0-CGGGATCCTCGGCATCAA). A primer extension reaction was
performed to make double-stranded, 32P-labeled oligonucleotides,
which were puriﬁed by PAGE. 10 lg of GST-Zfp496 was incubated
with 1 lg of poly (dI-dC) in the Reaction Buﬀer (10 mM Tris, pH
8.0, 1 mM dithiothreitol, 1 mM NaH2PO4, 5% glycerol, 50 mM NaCl,
and protease inhibitors) for 10 min on ice. 2 lg of 32P-labeled random
double-stranded probe was added for 20 min at room temperature and
subjected to GMSA. After the shifted band was excised, the DNA was
eluted from the gel and ampliﬁed using 15 PCR cycles. The selection
procedure was repeated for four rounds. After the last round of selec-
tion, PCR-ampliﬁed products were directly subcloned into the pCRII-
TOPO vector and sequenced. These oligonucleotides were then sub-
jected to GMSA to conﬁrm their binding to Zfp496.3. Results
3.1. Zfp496 physically associates with JMJ in vivo
In this study, Zfp496 was identiﬁed as a potential cofactor of
JMJ using a yeast two-hybrid screen. The recovered cDNA
from yeast contained the last two zinc ﬁnger motifs, suggesting
that this zinc ﬁnger region of Zfp496 is suﬃcient to interact
with JMJ in yeast. To investigate whether Zfp496 associates
with JMJ in vivo, coimmunoprecipitation experiments were
performed using HEK 293 cells overexpressing Zfp496 and
JMJ (Fig. 1). As shown in Fig. 1A, Zfp496-myc protein was
detected (lane 2) when the cell extract coexpressing FLAG-
tagged JMJ (JMJ-FLAG) was immunoprecipitated with anti-
FLAG antibody, followed by Western blotting with anti-myc
antibody. Zfp496 was not detected when the control cell
extract expressing only Zfp496-myc was used (lane 1), indicat-
ing the speciﬁc interaction of JMJ with Zfp496. The converse
coimmunoprecipitation experiment also revealed the speciﬁc
interactions of Zfp496 with JMJ in vivo (Fig. 1B). When the
cell extract containing Zfp496-myc and JMJ-FLAG was
immunoprecipitated with anti-myc antibody, Zfp496 was able
Fig. 1. Zfp496 physically interacts with JMJ in vivo. Coimmunopre-
cipitation was performed using HEK293 cells transected with FLAG-
tagged JMJ and myc-tagged Zfp496. (A) Cell lysates were immuno-
precipitated (IP) with anti-FLAG antibody followed by immunoblot-
ting (IB) with anti-myc antibody. Lanes 3 and 4 represent direct
Western blotting of the cell lysates and are 4% of the input of co-ip. (B)
The reverse experiment was done to conﬁrm the protein interaction.
Cell lysates were immunoprecipitated with anti-myc antibody followed
by immunoblotting with an anti-FLAG antibody. Lanes 3 and 4
represent direct Western blotting of the cell lysates and are 4% of the
input of the co-ip. (C) Semi in vivo GST-pull-down assay. Protein
extract from mouse heart was incubated with GST beads (lane 1) or
GST-Zfp496 beads (lane 2) followed by Western blotting using the
JMJ antibody. Direct Western blotting of 10T 1/2 control cells (lane 3)
or heart extract (lane 4) is shown as controls.
Fig. 2. Mapping of protein interaction sites in vitro. (A) In vitro 35S-Zfp496-fu
528) or GST-J-Ct (aa 529–1234) linked to agarose beads. The bound proteins
through d are: Zfp496-FL (aa 1–585), Zfp496-SCAN only (aa 1-198), Zfp496
respectively. (B) In vitro 35S-FL-JMJ and JMJ mutants were incubated with
FL-JMJ aa 1–1234, JMJ aa 1–220, JMJ aa 1–130 (NLS), and JMJ aa 131–22
792) is indicated. (, no interaction; +, interaction; ++, strong interaction).
M.R. Mysliwiec et al. / FEBS Letters 581 (2007) 2633–2640 2635to pull down JMJ (lane 2). JMJ was not detected when coim-
munoprecipitation was performed with anti-myc antibody in
the cell extract containing only JMJ-FLAG (lane 1). These
data clearly demonstrate that Zfp496 physically associates
with JMJ in vivo when the proteins are coexpressed.
To further show the in vivo interaction between Zfp496 and
JMJ, a semi in vivo GST-pull-down experiment was performed
using heart extracts. As shown in Fig. 1C, this result clearly
shows that GST-Zfp496 is able to interact with endogenous
JMJ expressed in the heart. The JMJ band was detected when
heart extracts were incubated with GST-Zfp496 (lane 2), but
not with GST alone (lane 1). Direct Western blotting shows
the single JMJ band in the heart extract (lane 4), but not in
the 10T1/2 control cells (lane 3). The reciprocal experiment
could not be performed due to lack of a suitable Zfp496 anti-
body.
3.2. The N-terminal of JMJ interacts with the zinc ﬁnger region
of Zfp496 in vitro
To investigate the regions involved in the protein–protein
interaction between Zfp496 and JMJ, GST pull-down assays
were performed (Fig. 2). The JMJ protein contains several do-
mains which have been previously described [24]. The nuclear
localization signal (NLS) of JMJ is present between aa 1 and
aa 131. The region responsible for transcriptional repression
(TR) is comprised of aa 132–222 [24]. JMJ-C-terminal mutant
(J-Ct, aa 529–1234) consists of the JmjN, ARID, and JmjC do-
mains, which includes the DNA-binding domain (DBD). The
JMJ-N-terminal mutant (J-Nt) consists of aa 1–528. 35S-la-
beled full length (Fig. 2A, panel a) and Zfp496 mutants (panels
b, c and d) (lane 1) were incubated with GST (lane 2), GST-J-
Nt (lane 3), or GST-J-Ct (lane 4) coupled to agarose beads.
Full length-Zfp496 was able to bind to the GST-J-Nt but
not GST-J-Ct (panel a). Neither Zfp496-SCAN only mutantll length (FL) and mutants were incubated with GST, GST-J-Nt (aa 1–
were resolved using SDS-PAGE followed by autoradiography. Panels a
-KRAB only (aa 155–333), and Zfp496-zinc ﬁnger only (aa 333–585),
GST or GST-Zfp496 linked to agarose beads. Panels a through d are:
2 (TR), respectively. The DNA-binding domain of JMJ (DBD, aa 529–
2636 M.R. Mysliwiec et al. / FEBS Letters 581 (2007) 2633–2640(aa 1–198, panel b) nor the Zfp496-KRAB only mutant (aa
155–333, panel c) was able to bind to GST-J-Nt or GST-J-
Ct. Zfp496-zinc only (aa 333–585, panel d) did bind to GST-
J-Nt but not GST-J-Ct. This assay indicates that Zfp496 and
JMJ can interact in vitro and the interaction is between the
N-terminal region of JMJ and the zinc ﬁnger region of
Zfp496, which is consistent with the result of yeast two-hybrid
screening.
To perform the reciprocal experiment (Fig. 2B), 35S-JMJ
constructs (lane 1) including JMJ full length (FL, panel a),
JMJ 1–220 (panel b), JMJ 1–130 (panel c), and JMJ 131–222
(panel d) were incubated with GST (lane 2), or GST-Zfp496
(lane 3) coupled to agarose beads. GST-Zfp496 associated with
full length JMJ as well as with JMJ 1–220 and to a lesser extentFig. 3. Zfp496 and JMJ modulate each other’s transcriptional activities. (A) D
7 cells transfected with Zfp496-Xpress mutants were subjected to immunos
antibody coupled to AlexaFluor488 (Molecular Probes) (top panel). Nuclei
Fluorescence was visualized using a Zeiss Axiovert 200 microscope. The struc
well plates were transfected with various plasmids using calcium phosphate.
map the region of Zfp496 that was responsible for the activation, Zfp496 mu
and zinc ﬁnger domain) and GAL4-Zfp496 aa 333–585 (zinc ﬁnger only) we
and 400 ng). (D) GAL4-Zfp496 (50 ng), and pG5Ti (500 ng) were cotransfec
(100 ng), and pG5Ti (500 ng) were cotransfected with or without Zfp496 (
galactosidase activity and the activity was set at one for the reporter gene
experiments of duplicate plates. Western blots of protein extracts corresponJMJ 131–222. Zfp496 did not associate with JMJ 1–130, indi-
cating that Zfp496 interacts with the TR domain of JMJ and
that the TR domain of JMJ is suﬃcient for the interaction.
The results indicate that the zinc ﬁnger region of Zfp496 inter-
acts with the TR domain of JMJ in vitro. For all GST-pull-
down experiments, GST alone did not bind to any of the
35S-proteins indicating speciﬁcity of the protein interactions
between JMJ and Zfp496. Other 35S-JMJ-C terminal proteins
such as JMJ aa 529–792 were tested in the assay and showed
no interaction (data not shown).
3.3. Zfp496 functions as a transcriptional activator
Next, we identiﬁed where the nuclear localization signal
(NLS) of Zfp496 was located. This information is necessaryetermination of the nuclear localization signal (NLS) in Zfp496. COS-
taining using the anti-Xpress antibody (Invitrogen) and a secondary
were stained with Hoechst 33342 (Molecular Probes) (bottom panel).
tures of the mutants are shown in Fig. 2. (B) 10T1/2 cells cultured in 6-
GAL4-Zfp496 was cotransfected with pG5Ti reporter (500 ng). (C) To
tants that localized to the nucleus, GAL4-Zfp496 aa 155–585 (KRAB
re cotransfected with pG5Ti (500 ng) in varying doses (100 ng, 200 ng,
ted with or without JMJ (100 ng, 200 ng, and 400 ng). (E) GAL4-JMJ
20 ng and 50 ng). Relative luciferase activity was standardized to b-
transfected alone. Each graph represents at least three independent
ding to ﬁrst three transfection conditions in (D) and (E) are shown.
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reporter gene assays. Therefore, deletion mutants of Zfp496
were made in the GAL4-Zfp496-Xpress tag vector. The
mutants included the SCAN region alone (aa 1–198), KRAB
A box region alone (aa 155–333), and zinc ﬁnger region alone
(aa 333–585). As Fig. 3A shows, the full length and the zinc
ﬁnger only mutant localized to the nucleus. Mutants contain-
ing only the SCAN region or the KRAB A box region local-
ized to the cytoplasm. Therefore, the NLS is located in the
zinc ﬁnger region of the Zfp496 protein, which contains a puta-
tive NLS sequence, KRRSK (aa 575–579).
Based on the fact that Zfp496 contained a KRAB A box and
a zinc ﬁnger domain, we hypothesized that Zfp496 functions as
a transcription factor. A plasmid encoding the GAL4 DNA-
binding domain fused to Zfp496 (GAL4-Zfp496) was transfec-
ted with a reporter vector pG5Ti consisting of GAL4
DNA-binding sites upstream of the luciferase gene [33]. Inter-
estingly, Zfp496 showed transcriptional activation of the repor-
ter gene up to 10 fold compared to the reporter gene alone in a
dose-dependent manner (Fig. 3B). This activation was achieved
with a relatively low dose of Zfp496 making it a potent tran-
scriptional activator. This is very interesting because transcrip-
tion factors containing a KRAB box were generally
characterized as transcription repressors. To further character-
ize Zfp496, we investigated which region of the Zfp496 protein
was responsible for the activation by mutational analyses. We
cotransfected Zfp496 mutants that localize to the nucleus with
the pG5Ti reporter into 10T1/2 cells. The Zfp496 mutant (aa
333–585) containing only the zinc ﬁnger region completely lost
its activation function compared to that of the reporter gene
alone (Fig. 3C). However, Zfp496 (155–585) containing the
KRAB box and zinc ﬁnger region showed signiﬁcant activa-
tion, in a similar pattern to full length Zfp496. Taken together,
these data indicate that the KRAB box and zinc ﬁnger region of
Zfp496 are required for the activation of the reporter gene.
It is intriguing that Zfp496 shows the transcriptional activa-
tion whereas JMJ functions as a powerful transcriptional
repressor [24]. We next investigated whether JMJ modulates
the activation function of Zfp496 and vice versa since the
two proteins showed a physical interaction both in vitro and
in vivo. When cells were cotransfected with GAL4-Zfp496
and the reporter pG5Ti, JMJ signiﬁcantly inhibits the activa-Fig. 4. The regions of Zfp496 and JMJ responsible for modulating each othe
transfected with various plasmids using Lipofectamine 2000. (A) GAL4-Zfp4
JMJ constructs. Results are shown where GAL4-Zfp496 was set at 100%. (
diﬀerent Zfp496 constructs. Relative luciferase activity was standardized and
independent experiments of duplicate plates.tion function of Zfp496 in a dose-dependent manner
(Fig. 3D). JMJ alone did not inhibit the reporter gene activities
(data not shown). The reciprocal experiment was performed to
determine whether Zfp496 attenuates the repression function
of JMJ (Fig. 3E). Zfp496 signiﬁcantly inhibited the repression
function of JMJ in a dose-dependent manner. Zfp496 transfec-
ted with only pG5Ti had no eﬀect on the reporter gene activ-
ities (data not shown). These data demonstrate that the two
factors attenuate each other’s transcriptional function likely
via protein–protein interaction. To eliminate the possibility
that JMJ inhibited the activation function of Zfp496 by inhib-
iting the expression of Zfp496, Western blotting was per-
formed. As shown in Fig. 3D and E, cotransfection of JMJ
or Zfp496 did not inhibit the expression level of Zfp496 or
JMJ, respectively.
3.4. Characterization of functional interaction between Zfp496
and JMJ
Next we investigated whether the physical interaction be-
tween JMJ and Zfp496 is suﬃcient for this attenuation.
GAL4-Zfp496 was transfected with the pG5Ti reporter vector
with various JMJ mutants (Fig. 4A). Full length JMJ (FL) and
a JMJ mutant containing the NLS and TR domain (1–220)
were able to signiﬁcantly repress the activation of Zfp496.
However, a JMJ mutant containing the C-terminal domain
fused to the NLS (CT + NLS) showed no signiﬁcant inhibition
of this activation. Because J-Ct (aa 529–1234) localizes to the
cytoplasm, the NLS was fused to this mutant to allow the
J-Ct to be expressed in the nucleus. These data indicate that
the TR domain of JMJ, which is the physical interaction do-
main, is necessary and suﬃcient to attenuate the transcrip-
tional activation function of Zfp496.
We next investigated whether the zinc ﬁnger region, the
physical interaction domain, was suﬃcient for the functional
inhibition of the transcriptional repression of JMJ. GAL4-
JMJ was transfected with the pG5Ti reporter vector along with
various Zfp496 mutants that showed nuclear localization
(Fig. 4B). Full length Zfp496 (FL) was able to signiﬁcantly in-
hibit the repression of GAL4-JMJ. However, constructs of
Zfp496 comprised of KRAB + zinc ﬁnger only (KZ), zinc ﬁn-
ger only (ZF), and SCAN + zinc ﬁnger only (S + ZF) showed
no signiﬁcant inhibition of this repression. These data indicater’s transcriptional activities. 10T1/2 cells cultured in 12-well plates were
96 (75 ng) was cotransfected with pG5Ti reporter (200 ng) and diﬀerent
B) GAL4-JMJ (150 ng), and pG5Ti (200 ng) were cotransfected with
calculated as described in Fig. 3. Each graph represents at least three
Fig. 5. Zfp496 can bind DNA and activate SAAB reporter gene constructs. (A) Representative GMSA using GST-Zfp496 and the DNA-binding
motif #18 selected by SAAB. Lane 1: #18 probe alone. Lane 2: Probe plus 2.5 lg GST only. Lanes 3 and 4: Probe plus 0.5 lg and 1.5 lg GST-
Zfp496, respectively. The binding mixture was subjected to non-denatured PAGE and autoradiographed. B. Transient transfection assays were
performed in 10T1/2 cells cultured in 6-well plates using the reporter (50 ng) and Zfp496 (50 ng, 100 ng, 200 ng) using Lipofectamine 2000. Relative
luciferase activity was calculated as in Fig. 3. (C) The oligonucleotide sequences of the high aﬃnity DNA-binding sites selected by SAAB are shown.
The underlined letters indicate binding sites of homeobox proteins. * indicates the oligonucleotides that were identiﬁed twice each. (D) Transfection
assays were performed in 10T1/2 cells in 12-well plates using the reporter (300 ng), Zfp496 (400 ng) and JMJ (250 ng, 500 ng, 1000 ng) using
Lipofectamine 2000. Each graph in (B) and (C) represents at least three independent experiments of duplicate plates.
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physical interaction with JMJ, it is not suﬃcient to modulate
the transcriptional repression function of JMJ. Rather, all
three deﬁned domains of Zfp496 seem to be required for a
functional interaction with JMJ. However, we cannot exclude
a possibility that deletions in the Zfp496 mutants cause confor-
mational changes in Zfp496 resulting in a loss of functional
modulation.
3.5. Zfp496 can bind to DNA and activate reporter genes
containing its DNA-binding sites
Thus far our data indicate the transcriptional activation
function of Zfp496 when it is tethered to DNA using a
GAL4 reporter system. Next, we sought to determine if
Zfp496 was able to bind to DNA by performing SAAB since
the zinc ﬁnger domain can function as a DNA-binding do-
main. Our SAAB assays produced 16 possible binding oligonu-
cleotides in vitro, all of which were conﬁrmed to bind to
Zfp496 using GMSA (see Fig. 5A). Eight of the SAAB oligo-
nucleotides showed high aﬃnity binding while the rest of the
SAAB oligonucleotides showed lower aﬃnity binding. Of the
eight oligonucleotides showing high aﬃnity binding, two oligo-
nucleotides (#3 and #18) were identiﬁed twice, suggestingthese two oligonucleotides are likely bona ﬁde binding sites
for Zfp496 (Fig. 5C).
We reasoned that the high aﬃnity binding motifs that were
enriched by SAAB (#3 and #18) would reﬂect the functional
cis-elements in target gene regulation. Therefore, we investi-
gated whether Zfp496 could activate a reporter gene contain-
ing these selected binding sites in pGL2-E1B. Transient
transfection assays showed that Zfp496 activated all three
reporter genes containing the DNA-binding motifs selected
by SAAB in a dose-response manner (Fig. 5B). These data
demonstrate that Zfp496 can function as a DNA-binding tran-
scriptional activator. It should be noted that ﬁve out of a total
of six high aﬃnity binding sites contain a –TAAT– like motif
(underlined in Fig. 5C) that is a homeobox protein binding
site. Initial comparison of all of the SAAB oligonucleotide se-
quences revealed no obvious consensus binding sequence. JMJ
also represses the function of Zfp496 when the reporter gene
contains Zfp496 DNA binding sites. When Zfp496 was trans-
fected with pGL2-E1B-5X SAAB #3 or #4 (data not shown)
or #18 (Fig. 5D) with or without JMJ, JMJ showed a similar
repression function of Zfp496 as in the GAL4 system. JMJ
alone did not repress the activity of the reporter gene (data
not shown).
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In this study, we showed that JMJ physically interacted with
Zfp496, a SCAN-KRAB-zinc ﬁnger protein in vivo and
in vitro. The zinc ﬁnger region of Zfp496 was required for
interaction with the N-terminal part of JMJ containing the
transcriptional repression domain [24]. Further, JMJ and
Zfp496 attenuated the transcriptional function of each other
when they are coexpressed.
It is interesting to note that Zfp496 functions as a transcrip-
tional activator, although it encodes a KRAB A domain that
generally functions as a repressor. It is not known how
Zfp496 can function as an activator (Figs. 3–5) or repressor
[30]. Increasing evidence indicates that one transcription factor
can function as an activator or a repressor depending on cofac-
tors and/or promoter context including bifunctional transcrip-
tion factor YY1 [37]. The nuclear receptors can activate or
silence the target gene expression depending on the cofactors
[38,39]. Therefore, it is possible that Zfp496 functions as either
an activator or repressor depending on cofactors and promoter
context. Our SAAB and GMSA results conﬁrm that Zfp496 is
able to bind DNA in vitro and therefore function as a DNA-
binding transcription modulator. In addition, all reporter con-
structs tested containing the DNA-binding sites of Zfp496
identiﬁed by SAAB were activated by Zfp496 (Fig. 5B). How-
ever, we cannot rule out the possibility that the expression of
other target genes would be repressed by Zfp496. Further,
the possibility exists that the transient transfection system
lacks the cofactors necessary to show a transcriptional repres-
sor function of Zfp496. However, our data strongly favor the
transcriptional activation function of Zfp496 since a small
dose of Zfp496 exhibited activation of two completely diﬀerent
reporter gene systems (Figs. 3 and 5).
The KRAB box is found in about one-third of the human
genes encoding Kru¨ppel-type C2H2 zinc ﬁngers (for review
see [29]). KRAB-zinc ﬁnger proteins require speciﬁc cofactors
to show transcriptional repression. Namely, they require both
KAP-1/TIF-1B and the SET containing protein SETDB1 to
function as a repressor [40]. Our ﬁnding of a transcriptional
activation function of Zfp496 is supported by recent reports
that ZNF641 and ZNF480 [41,42] which contain a KRAB
and a zinc ﬁnger domain, and ZNF445 [43], which contains
a SCAN, KRAB and zinc ﬁnger domain weakly activate the
reporter genes containing AP-1 or serum response element
(SRE) sequence. It should be noted that the mechanisms for
the weak/marginal activation shown in these articles have
not been investigated. Our mutational assays indicated that
the KRAB-zinc ﬁnger domains were suﬃcient for the tran-
scriptional activation function while the zinc ﬁnger (nuclear
localization signal domain) alone completely lost its activation
function.
One of three classes of SCAN family members consists of a
SCAN-KRAB-zinc ﬁnger modular architecture, where the
KRAB domain may be complete or more frequently consist
of only the A domain, which is the case for Zfp496. Among
more than 500 Kru¨ppel-type zinc ﬁnger factors encoded in
the human genome, about 17 genes contain some variation
of the SCAN-KRAB-zinc ﬁnger structure similar to Zfp496.
Although the functions of these proteins are largely unknown,
some interesting members of this subgroup of SCAN family
members are ZNF202, and ZNF215. ZNF202 is the hypoal-
phalipoproteinemia susceptibility gene that encodes a tran-scriptional repressor that binds to elements found in genes
that participate in lipid metabolism [44]. ZNF215 may be asso-
ciated Beckwith–Wiedemann syndrome, a disorder character-
ized by growth abnormalities [45]. These examples illustrate
that members of the SCAN-KRAB-zinc ﬁnger protein family
are involved in a diverse set of biological functions.
Although we show that Zfp496 is able to interact with and
modulate the function of JMJ, the biological signiﬁcance of
these interactions remains to be elucidated. Since it has been
shown that JMJ is involved in regulation of cell cycle and
ANF expression in cardiomyocytes during development
[25,26,28], it is plausible that Zfp496 regulates these processes
by modulating the function of JMJ. Although not cardiac-spe-
ciﬁc genes, both factors are co-expressed in the developing
heart at a higher level than the adult heart by Northern blot
analyses (data not shown). The present study provides the
important platform to further study functional importance of
this modulation as well as to identify the endogenous target
genes that are co-regulated by both factors.
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